Inari Medical Analysis
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
Inari Medical is overvalued with Real Value of 61.39 and Hype Value of 79.97. The main objective of Inari Medical delisted stock analysis is to determine its intrinsic value, which is an estimate of what Inari Medical is worth, separate from its market price. There are two main types of Inari Medical's stock analysis: fundamental analysis and technical analysis.
The Inari Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Inari Medical's ongoing operational relationships across important fundamental and technical indicators.
Inari |
Inari Stock Analysis Notes
About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 275.35. Inari Medical recorded a loss per share of 1.35. The entity had not issued any dividends in recent years. Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people. To find out more about Inari Medical contact William Hoffman at 877 923 4747 or learn more at https://www.inarimedical.com.Inari Medical Investment Alerts
| Inari Medical is not yet fully synchronised with the market data | |
| Inari Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 498.76 M. | |
| Over 96.0% of the company shares are owned by institutional investors |
Inari Medical Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inari Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Inari Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.68 B.Inari Profitablity
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.Inari Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inari Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inari Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inari Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inari Medical Outstanding Bonds
Inari Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Inari Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Inari bonds can be classified according to their maturity, which is the date when Inari Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Inari Medical Predictive Daily Indicators
Inari Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Inari Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Inari Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Inari Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inari shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Inari Medical. By using and applying Inari Stock analysis, traders can create a robust methodology for identifying Inari entry and exit points for their positions.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Inari Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |